Current status of quality of life measurement in lung cancer patients.

2.50
Hdl Handle:
http://hdl.handle.net/10541/108000
Title:
Current status of quality of life measurement in lung cancer patients.
Authors:
Hopwood, Penelope; Thatcher, Nick
Abstract:
Quality of life in patients with inoperable lung cancer receiving palliative treatment has become an important issue. As in other types of cancer, lack of standardization of quality of life data makes comparison between trials difficult, sometimes even impossible. Much effort is being given to the development of suitable instruments to measure quality of life and strategies to incorporate these measurements into clinical trials. The authors review studies in palliative lung cancer treatment where two crucial questions are being addressed: Do patients improve in performance status and symptom relief and does treatment toxicity outweigh disease palliation?
Affiliation:
Department of Medical Oncology, Christie Hospital and Holt Radium Institute, Manchester, UK.
Citation:
Current status of quality of life measurement in lung cancer patients. 1991, 5 (5):159-166; discussion 166, 169, 173 Oncology
Journal:
Oncology
Issue Date:
May-1991
URI:
http://hdl.handle.net/10541/108000
PubMed ID:
1715734
Type:
Article
Language:
en
ISSN:
0890-9091
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorHopwood, Penelopeen
dc.contributor.authorThatcher, Nicken
dc.date.accessioned2010-07-21T08:58:31Z-
dc.date.available2010-07-21T08:58:31Z-
dc.date.issued1991-05-
dc.identifier.citationCurrent status of quality of life measurement in lung cancer patients. 1991, 5 (5):159-166; discussion 166, 169, 173 Oncologyen
dc.identifier.issn0890-9091-
dc.identifier.pmid1715734-
dc.identifier.urihttp://hdl.handle.net/10541/108000-
dc.description.abstractQuality of life in patients with inoperable lung cancer receiving palliative treatment has become an important issue. As in other types of cancer, lack of standardization of quality of life data makes comparison between trials difficult, sometimes even impossible. Much effort is being given to the development of suitable instruments to measure quality of life and strategies to incorporate these measurements into clinical trials. The authors review studies in palliative lung cancer treatment where two crucial questions are being addressed: Do patients improve in performance status and symptom relief and does treatment toxicity outweigh disease palliation?en
dc.language.isoenen
dc.subjectLung Canceren
dc.subject.meshClinical Trials as Topic-
dc.subject.meshEvaluation Studies as Topic-
dc.subject.meshHumans-
dc.subject.meshLung Neoplasms-
dc.subject.meshPalliative Care-
dc.subject.meshQuality of Life-
dc.titleCurrent status of quality of life measurement in lung cancer patients.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology, Christie Hospital and Holt Radium Institute, Manchester, UK.en
dc.identifier.journalOncologyen
All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.